This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n8http://linked.opendata.cz/resource/drugbank/drug/DB02241/identifier/drugbank/
n13http://linked.opendata.cz/resource/drugbank/drug/DB02241/identifier/chemspider/
n11http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n14http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n9http://linked.opendata.cz/resource/drugbank/drug/DB02241/identifier/pdb/
n4http://linked.opendata.cz/resource/drugbank/property/
n6http://linked.opendata.cz/resource/drugbank/drug/DB02241/identifier/pubchem-compound/
xsdhhttp://www.w3.org/2001/XMLSchema#
n7http://linked.opendata.cz/resource/drugbank/drug/DB02241/identifier/pubchem-substance/

Statements

Subject Item
n2:DB02241
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n11:DB02241 n14:DB02241
dcterms:title
8-Benzyl-2-Hydroperoxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One
adms:identifier
n6:46936330 n7:46506413 n8:DB02241 n9:CZH n13:2412
n3:IUPAC-Name
n4:271B4AF7-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4AFD-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4AFC-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4AF9-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4AFA-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4AFB-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4AF5-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4AF6-363D-11E5-9242-09173F13E4C5 n4:271B4AF3-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4AF4-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4B03-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4B04-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4AFE-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4AFF-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4B01-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4B00-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4B02-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4B09-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4B0B-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4B0C-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4B08-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4B07-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4B0A-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4AF8-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4B05-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4B06-363D-11E5-9242-09173F13E4C5